OOIR: Observatory of International Research

Papers

(The TQCC of Netherlands Heart Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Older patients with non-ST-elevation myocardial infarction: which treatment strategies do we currently use?	40
A young man with DiGeorge syndrome and tachycardia	29
Electrocardiographic ST-segment elevation with prominent R waves in precordial leads	18
Current gaps in knowledge in inherited arrhythmia syndromes	16
Impact of geriatric co-management on outcomes in hospitalised cardiology patients aged 85 and over	15
Does it take two to tango?	14
Omega-3 fatty acids in heart disease—why accurately measured levels matter	14
Reply to ‘Cost-effectiveness of long term left ventricular assist devices’	14
Changes in demographics, treatment and outcomes in a consecutive cohort who underwent transcatheter aortic valve implantation between 2005 and 2020	13
Studies on ICD guidelines, cardiac amyloidosis in HFpEF, and remote monitoring outcomes	13
Renal denervation revisited; should we pay attention?	12
Cardiac resynchronisation therapy in optima forma	12
Arterial stiffness and atrial fibrillation recurrence: another risk marker or a call for better management of concomitant disease?	11
Stacking of antithrombotic drugs in cardiology: evidence-based customisation	11
Sodium-glucose cotransporter 2 inhibitors: a practical guide for the Dutch cardiologist based on real-world experience	10
2021 European Society of Cardiology guidelines on cardiac pacing and cardiac resynchronisation therapy	10
Defining left bundle branch block according to the new 2021 European Society of Cardiology criteria	10
The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis	10
No substantial excess all-cause mortality among cardiac implantable electronic device patients during the first COVID‑19 lockdown in the Leiden area	9
Data quality and auditing within the Netherlands Heart Registration: using the PCI registry as an example	9
COVID-19-mediated patient delay caused increased total ischaemic time in ST-segment elevation myocardial infarction	9
Transcatheter aortic valve replacement: impact of pre-procedural FEops HEARTguide assessment on device size selection in borderline annulus size cases	9
Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trial	9
A young man with DiGeorge syndrome and tachycardia	8
Improved prehospital triage for acute cardiac care: results from HART-c, a multicentre prospective study	8

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms	8
SCN5A-1795insD founder variant: a unique Dutch experience spanning 7 decades	8
Characteristics and outcomes of COVID-19 in heart transplantation recipients in the Netherlands	8
Pulsed field versus cryoballoon ablation for atrial fibrillation: a real-world observational study on procedural outcomes and efficacy	7
Demographics and outcomes of patients younger than 75 years undergoing aortic valve interventions in Rotterdam	7
CT is the new standard for the diagnosis of coronary artery disease in daily practice	7
The role of artificial intelligence in coronary CT angiography	7
The spells of iatrogeny	7
Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry	7
The impact of the multidisciplinary Endocarditis Team on the management of infective endocarditis	7
Intramyocardial left anterior descending unroofing using a minimally invasive off-pump approach	7
Abnormal repolarisation after a game of Jass	7
Essential thrombocytosis: diagnosis, differential diagnosis, complications and treatment considerations of relevance for a cardiologist	7
Implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy: a need or not?	7
Novel sites for pacemaker lead implantation and different routes for their extraction	6
Yield of family screening for dilated cardiomyopathy: 10-year experience at a multidisciplinary cardiogenetic outpatient clinic	6
Atrial fibrillation and what else?	6
A rare cause of narrow QRS complex tachycardia: the tortoise and the hare	6
The Dutch Idiopathic Ventricular Fibrillation Registry: progress report on the quest to identify the unidentifiable	6
The Netherlands Heart Tissue Bank	6
A rare finding on computed tomography angiography performed to exclude pulmonary embolism	6
How often are imaging studies for thoracic aortic aneurysm necessary?	6
‘An ounce of prevention is worth a pound of cure’	6
Referral to and enrolment in cardiac rehabilitation after open-heart surgery in the Netherlands	5
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials	5
Rationale and design of the iCORONARY trial: improving the cost-effectiveness of coronary artery disease diagnosis	5
Cardiac rehabilitation for patients with obesity: lessons learned from the OPTICARE XL trial	5
Data quality within the Netherlands Heart Registration: Ready for prime time?	5
Building a patient-centred nationwide integrated cardiac care registry: intermediate results from the Netherlands	5
CT-derived FFR: beyond anatomy	5
Diagnostic accuracy of on-site coronary computed tomography-derived fractional flow reserve in the diagnosis of stable coronary artery disease	5
The MIS-HF in clinical practice	5
Pre-hospital rule-out of acute coronary syndrome by modified HEART score assessment including point-of-care troponin	5
Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest: an overview of current practice and evidence	4
The PLN Foundation is striving for a cure, but who owns the disease?	4
Integration of sex and gender in cardiovascular medicine: a scientific and clinical imperative	4
National indication document and aortic valve replacement landscape in the Netherlands	4
Electrocardiographic ST-segment elevation with prominent R waves in precordial leads	4
The WOEST 2 registry	4
Major threats to early safety after transcatheter aortic valve implantation in a contemporary cohort of real-world patients	4
Atrial fibrillation and what else?	4
Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant?	4
Is there anything else to fish out of this “fishy” electrocardiogram?	4
Substance of ‘phantom’ cardiac masses confirmed by therapeutic outcome	4
Report on outcomes of valve-in-valve transcatheter aortic valve implantation and redo surgical aortic valve replacement in the Netherlands	4
Transcatheter aortic valve implantation under 75 years of age: only for high surgical risk patients; but for how long?	4
Global longitudinal strain: an early marker for cardiotoxicity in patients treated for breast cancer	4
Welcome from the new editor-in-chief	4
Percutaneous left stellate ganglion block for refractory ventricular tachycardia in structural heart disease: our single-centre experience	4
Extraction of non-infected redundant pacing and defibrillator leads does not result in better patient outcomes	4

An appeal to our government for nationwide policies in the prevention of cardiovascular disease	4
A rare electrocardiographic sign of acute inferior myocardial infarction	4
Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial	3
ECPELLA as a bridge-to-decision in refractory cardiogenic shock: a single-centre experience	3
Exercise-based cardiac rehabilitation in stable angina pectoris: a narrative review on current evidence and underlying physiological mechanisms	3
Prevalence of transthyretin amyloid cardiomyopathy in an unselected cohort with heart failure with preserved ejection fraction	3
Tracing triggers of cardiac remodelling and heart failure	3
Sex difference in outcomes after coronary artery bypass grafting: follow-up data of the Netherlands Heart Registration	3
Coronary computed tomographic angiograph as gatekeeper?—The gate is wide open	3
Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)	3
Towards individualised treatment of out-of-hospital cardiac arrest patients: an update on technical innovations in the prehospital chain of survival	3
Impact of symptom duration and mechanical circulatory support on prognosis in cardiogenic shock complicating acute myocardial infarction	3
Bioprosthetic mitral valve thrombosis	3
Morning pulmonary artery pressure measurements by CardioMEMS are most stable and recommended for pressure trends monitoring	3
Medications that interact with direct-acting oral anticoagulant exposure	3
Left bundle branch pacing: a promising modality for cardiac resynchronisation therapy	3
Percutaneous closure of postsurgical thoracic aorta pseudoaneurysms: the why, when, and how	3
Biomarkers for cardiovascular risk prediction: from pioneering to evidence-based use in clinical practice	3
Design and rationale of the South-East Netherlands Heart Registry (ZON-HR)	3
Interventions to prevent postoperative atrial fibrillation in Dutch cardiothoracic centres: a survey study	3
Desmoplakin cardiomyopathy—an inherited cardiomyopathy presenting with recurrent episodes of acute myocardial injury	3
Cognitive impairment and depression in heart failure: ‘cardiological giants’	3
Focal myocardial effects in infective endocarditis	3
Advancing cardiovascular care—key insights from the Netherlands Heart Journal 2024	3